The kidneys make urine, filter substances from the bloodstream, and are important in maintaining body chemistry. Permanent damage to the kidneys is called chronic kidney disease (CKD). Some common medical conditions that can cause CKD are diabetes, hypertension (high blood pressure), inherited kidney diseases, diseases of the kidney tissue itself, and chronic obstruction of the bladder. Some medications can have adverse effects that damage the kidneys. The kidneys also may be permanently impaired by a severe illness, such as heart failure or sepsis. Chronic kidney disease can progress to complete loss of kidney function, known as end-stage renal disease (ESRD). The September 12, 2007, issue of JAMA includes an article about CKD and ESRD.
Diabetes
Hypertension
Vascular (blood vessel) disease
Family history of kidney problems
Bladder obstruction
Grahic Jump Location
Physical examination, including blood pressure measurement
Blood tests, including complete blood count and chemistries
Urine testing
X-ray studies, including computed tomography (CT) scan, intravenous pyelography (an x-ray dye study of the kidney and its drainage system), and angiography (dye injected to outline the blood supply of the kidney)
Ultrasound of the abdomen
Cardiac and blood vessel testing may be recommended in persons at risk of heart disease or vascular disease.
Controlling high blood pressure is important to limit further damage to the kidney as well as to protect against heart attack and stroke. Managing blood sugar in individuals with diabetes is important. Modification of diet, such as limiting protein and salt intake, can be helpful to reduce symptoms of kidney failure. Since anemia (low red blood cell number) is common in persons with CKD or ESRD, medications that increase the red blood cell count may be prescribed.
Dialysis is a process that substitutes for the kidneys in filtering the blood and removing waste products. Persons with ESRD need dialysis to survive. Hemodialysis is filtration of the blood using blood vessel access through an arteriovenous access graft (material that is surgically placed, usually in the arm) or an arteriovenous fistula (a surgically created connection between an artery and a vein, also usually in the arm). Peritoneal dialysis may be prescribed for some patients and involves a tube placed into the abdominal cavity. Fluids introduced through this tube enable the removal of waste products.
Kidney transplantation is the ideal treatment for many patients with ESRD but the shortage of donor organs limits its availability. After surgery, the patient is required to take medications to prevent the body from rejecting the transplanted kidney.
National Kidney and Urologic Diseases Information Clearinghousehttp://www.kidney.niddk.nih.gov
National Kidney Foundationhttp://www.kidney.org
To find this and previous JAMA Patient Pages, go to the Patient Page link on JAMA's Web site at http://www.jama.com. Many are available in English and Spanish. A Patient Page on hypertensive kidney disease was published in the November 20, 2002, issue; one on kidney transplantation was published in the December 7, 2005, issue; and one on diabetes and the kidney was published in the June 25, 2003, issue.
Sources: National Institute of Diabetes and Digestive and Kidney Disease, American Diabetes Association, National Kidney Foundation
The JAMA Patient Page is a public service of JAMA. The information and recommendations appearing on this page are appropriate in most instances, but they are not a substitute for medical diagnosis. For specific information concerning your personal medical condition, JAMA suggests that you consult your physician. This page may be photocopied noncommercially by physicians and other health care professionals to share with patients. To purchase bulk reprints, call 203/259-8724.
TOPIC: KIDNEY DISEASE
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
Users' Guides to the Medical Literature We have found a strong, more or less consistent, independent, and biologically plausible...
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.